Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
  • C07D277/24—Radicals substituted by oxygen atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/426—1,3-Thiazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
  • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
  • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/02—Nasal agents, e.g. decongestants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/04—Antipruritics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P19/00—Drugs for skeletal disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P19/00—Drugs for skeletal disorders
  • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
  • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P27/00—Drugs for disorders of the senses
  • A61P27/02—Ophthalmic agents
  • A61P27/14—Decongestants or antiallergics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/08—Antiallergic agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
  • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Epidemiology (AREA)
• Physical Education & Sports Medicine (AREA)
• Rheumatology (AREA)
• Inorganic Chemistry (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Pulmonology (AREA)
• Ophthalmology & Optometry (AREA)
• Pain & Pain Management (AREA)
• Immunology (AREA)
• Otolaryngology (AREA)
• Dermatology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Thiazole And Isothizaole Compounds (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=36498212

Family Applications (1)

Country Status (19)

Families Citing this family (17)

Family Cites Families (12)

• 2005
  • 2005-11-22 AT AT05817697T patent/ATE445397T1/de active
  • 2005-11-22 DE DE602005017118T patent/DE602005017118D1/de active Active
  • 2005-11-22 KR KR1020050111779A patent/KR101047042B1/ko not_active IP Right Cessation
  • 2005-11-22 JP JP2007542909A patent/JP4773456B2/ja not_active Expired - Fee Related
  • 2005-11-22 WO PCT/KR2005/003950 patent/WO2006057507A1/en active Application Filing
  • 2005-11-22 CN CN200580038889A patent/CN100574756C/zh not_active Expired - Fee Related
  • 2005-11-22 BR BRPI0517396-5A patent/BRPI0517396A/pt not_active IP Right Cessation
  • 2005-11-22 DK DK05817697T patent/DK1701722T3/da active
  • 2005-11-22 CN CN2009101666678A patent/CN101693029B/zh not_active Expired - Fee Related
  • 2005-11-22 CA CA2585003A patent/CA2585003C/en not_active Expired - Fee Related
  • 2005-11-22 BR BRPI0514386A patent/BRPI0514386B8/pt active IP Right Grant
  • 2005-11-22 RU RU2007123614/04A patent/RU2361867C2/ru active
  • 2005-11-22 EP EP05817697A patent/EP1701722B1/en active Active
  • 2005-11-22 AU AU2005307994A patent/AU2005307994B2/en not_active Ceased
  • 2005-11-22 US US11/577,469 patent/US20070254930A1/en not_active Abandoned
  • 2005-11-22 JP JP2007523495A patent/JP4774053B2/ja active Active
  • 2005-11-22 PT PT05817697T patent/PT1701722E/pt unknown
  • 2005-11-22 ES ES05817697T patent/ES2333739T3/es active Active
  • 2005-11-22 CA CA2552766A patent/CA2552766C/en active Active
  • 2005-11-22 EP EP05821036A patent/EP1814593A4/en not_active Withdrawn
  • 2005-11-22 AU AU2005300239A patent/AU2005300239B2/en active Active
  • 2005-11-22 CN CN2005800017444A patent/CN1905871B/zh active Active
  • 2005-11-22 KR KR1020050111543A patent/KR100716389B1/ko active IP Right Review Request
  • 2005-11-22 US US10/584,984 patent/US20090176846A1/en not_active Abandoned
  • 2005-11-22 WO PCT/KR2005/003934 patent/WO2006057501A1/en active Application Filing
  • 2005-11-22 NZ NZ555725A patent/NZ555725A/en unknown
• 2007
  • 2007-01-17 ZA ZA200700485A patent/ZA200700485B/en unknown
  • 2007-01-25 IL IL180985A patent/IL180985A/en active IP Right Grant
  • 2007-02-08 HK HK07101468.4A patent/HK1094530A1/xx unknown
  • 2007-04-18 IL IL182647A patent/IL182647A/en not_active IP Right Cessation
  • 2007-05-24 ZA ZA200704236A patent/ZA200704236B/xx unknown

Also Published As

Similar Documents